Zobrazeno 1 - 10
of 241
pro vyhledávání: '"A. Rolevich"'
Autor:
Burdett, Sarah, Fisher, David J., Vale, Claire L., Sternberg, Cora N., Clarke, Noel W., Parmar, Mahesh K.B., Bono, Aldo V., Cognetti, Francesco, Collette, Laurence, Cote, Richard J., Goebell, Peter J., Groshen, Susan, Lehmann, Jan, Rolevich, Alexander I., Sonntag, Roland W., Stockle, Michael, Studer, Urs E., Torti, Frank M., Zhegalik, Alexander G., Tierney, Jayne F.
Publikováno v:
In European Urology January 2022 81(1):50-61
Autor:
Alexander I. Rolevich, Denis M. Borodin, Anton N. Rabcheuski, Tatsiana A. Ivanitskaya, Sviataslau A. Semenov, Liudmila V. Artsiushkevich, Alena V. Sukalinskaya, Edvard A. Zhavrid, Sergei A. Krasny, Natalia E. Konoplya, Sergey L. Polyakov
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 63-71 (2021)
PURPOSESince the development of the International Germ Cell Cancer Collaborative Group (IGCCCG) risk classification in a 1997 study, high-income countries have reported a significant increase in survival for poor prognosis patients. There are scant d
Externí odkaz:
https://doaj.org/article/31c77d13b62346d88211b5d7020a8233
Autor:
Ilya Tsimafeyeu, Oxana Shatkovskaya, Sergei Krasny, Nurzhan Nurgaliev, Ilya Varlamov, Vladislav Petkau, Sufia Safina, Ruslan Zukov, Mikhail Mazhbich, Galina Statsenko, Sergey Varlamov, Olga Novikova, Igor Zaitsev, Pavel Moiseyev, Alexander Rolevich, Alesya Evmenenko, Irina Popova, Dilyara Kaidarova, Liubov Vladimirova
Publikováno v:
Cancer Reports, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Background Real‐world data describing outcomes of treatment among metastatic renal cell carcinoma (mRCC) patients are limited and heterogeneous. Aim RENSUR3 registry study assessed real‐world data on the use of therapies in mRCC and over
Externí odkaz:
https://doaj.org/article/2f3fdafb12794e8ebeff801e78ecee6e
Autor:
Alexander G. Zhegalik, Claire L Vale, Urs E. Studer, Sonntag Rw, Jan Lehmann, Susan Groshen, Laurence Collette, Frank M. Torti, Francesco Cognetti, Jayne F. Tierney, Peter J. Goebell, Aldo V. Bono, Mahesh K. B. Parmar, Sarah Burdett, A. Rolevich, David Fisher, Richard J. Cote, Cora N. Sternberg, Michael Stöckle, Noel W. Clarke
Publikováno v:
European Urology
Take Home Message This systematic review and meta-analysis, based on updated individual participant data, demonstrates that cisplatin-based adjuvant chemotherapy is a valid option for improving outcomes for muscle-invasive bladder cancer.
Contex
Contex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91634727176f36a918d7f469154291f
https://doi.org/10.1016/j.eururo.2021.09.028
https://doi.org/10.1016/j.eururo.2021.09.028
Autor:
Tatsiana A Ivanitskaya, Natalia E Konoplya, Sergey L. Polyakov, Liudmila V Artsiushkevich, Anton N Rabcheuski, Sergei Krasny, Denis M Borodin, Alena V Sukalinskaya, Sviataslau A Semenov, A. Rolevich, Edvard A Zhavrid
Publikováno v:
JCO Global Oncology
PURPOSE Since the development of the International Germ Cell Cancer Collaborative Group (IGCCCG) risk classification in a 1997 study, high-income countries have reported a significant increase in survival for poor prognosis patients. There are scant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d6cebfd71279a113874f78962d2a78
https://doi.org/10.1200/go.20.00473
https://doi.org/10.1200/go.20.00473
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 19, Iss 5, Pp 638-646 (2015)
HRAS, KRAS and NRAS gene products belong to the superfamily of small GTPases. These proteins regulate cellular response to extracellular stimuli by means of activation of different signaling pathways. Although the role of RAS gene mutations in the pa
Externí odkaz:
https://doaj.org/article/23700143d88c48cf8511ae3c37040b6d
Autor:
Oleg Sukonko, A. Minich, Sergey L. Polyakov, Sergey Krasny, A. Rolevich, A. Mokhort, Alexander G. Zhegalik, Alexander N Volkov, Vladimir Ju Vasilevich
Publikováno v:
Central European Journal of Urology
Introduction This study assesses the efficacy and tolerability of two cycles of adjuvant chemotherapy (AC) with gemcitabine and cisplatin after radical cystectomy in patients with a high risk of progression of muscle-invasive urothelial bladder cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be71724e708c509142492d2eac636726
http://europepmc.org/articles/PMC7203780
http://europepmc.org/articles/PMC7203780
Publikováno v:
Onkourologiâ, Vol 4, Iss 2, Pp 31-35 (2020)
Purpose. Investigate prognostic solemnity of the clinical and laboratory values of the II stage bladder cancer patients and develop a nomogram allowing to predict a clinical outcome of this patient category. Materials and methods. Data of 299 BC pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::3a2c8d74a73c908f7db883b97f5641aa
https://oncourology.abvpress.ru/oncur/article/view/1098
https://oncourology.abvpress.ru/oncur/article/view/1098
Publikováno v:
Onkourologiâ, Vol 1, Iss 2, Pp 34-40 (2020)
The data of prospective randomized trial including comparative analysis of two treatment arm results are reported. The patients of group A underwent TUR with following intravesical electrophoresis of 50 mg of chemotherapeutic drug Doxorubicin whereas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::263ec03117937603bdc6d08923c4dd25
https://oncourology.abvpress.ru/oncur/article/view/1214
https://oncourology.abvpress.ru/oncur/article/view/1214
Publikováno v:
Onkourologiâ, Vol 3, Iss 3, Pp 35-41 (2020)
The data of 668 radical cystectomies were used to study the results of treatment in 151 (22,6%) patients with urinary bladder cancer (UBC) metastasizing to the regional lymph nodes and to evaluate the impact of lymphodissection extent on the detectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2a9642e02b5c9dad0a7f6b77f7b7e172
https://oncourology.abvpress.ru/oncur/article/view/1119
https://oncourology.abvpress.ru/oncur/article/view/1119